Citigroup
MANE

Citigroup’s Veradermics Inc MANE Stock Holding History

Citigroup’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
13,875
+3,184
+30% +$298K ﹤0.01% 3055
2026
Q1 		$675K Buy
+10,691
New +$539K ﹤0.01% 3369

Other funds holding MANE

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup's MANE Position: Q2 2026 in Review

Citigroup increased its Veradermics Inc (MANE) stake by 30% in Q2 2026, buying an estimated $298K and bringing the position to 13,875 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Citigroup first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Citigroup held 13,875 shares of Veradermics Inc worth $1.71M as of Q2 2026.
  • Citigroup bought 3,184 Veradermics Inc shares in Q2 2026, an estimated $298K.
  • Veradermics Inc made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3055 holding.
  • Citigroup first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.